Country comparison in spending on medicine 2026

In 2026, the United States is projected to spend between 685 and 715 billion U.S. dollars on medicine. Estimates for the United States are much higher than those of other countries on the list. For the same year, Germany’s expected expenditure estimates were between 76 and 96 billion U.S. dollars. China China stands in second place in terms of projected medicine expenditures for 2026, with estimates between 190 and 220 billion U.S. billion dollars. The country was also the world’s second-largest pharmaceutical market in 2020, accounting for eight percent of the world’s total pharmaceutical sales numbers. People in China spent the most on non-original branded pharmaceutical products, almost double as much as on original brands. Sinopharm Group Sinopharm Group Co., Ltd. is a Chinese pharmaceutical and biotech company, founded in 2003, and is one of the largest companies in the industry today. In 2021, the corporation generated around 80 billion U.S. dollars in revenue, placing them among the global top companies in that year.

至2026年，预计美国在医药领域的支出将在6850亿至7150亿美元之间。相较其他国家，美国的预估支出显著偏高。同年，德国的预期支出预估介于760亿至960亿美元。就2026年预期的医药支出而言，中国位居第二，预估支出介于1900亿至2200亿美元。该国在2020年也是全球第二大医药市场，占全球医药销售额总数的8%。中国人在非原创品牌医药产品上的支出最多，几乎是原创品牌的两倍。中国医药集团中国医药集团股份有限公司（Sinopharm Group Co., Ltd.），成立于2003年，是一家中国医药和生物技术公司，目前是行业中的领军企业之一。2021年，该集团实现了约800亿美元的年收入，使其成为当年全球顶尖企业之一。